StonvexLoading…
StonvexStonvexStonvexCore line items from MNKD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $348.97M | $285.50M | $198.96M | $99.77M |
Operating Income | $38.80M | $72.59M | $8.68M | $-64.11M |
Net Income | $5.86M | $27.59M | $-11.94M | $-87.40M |
EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 |
Total Assets | $792.18M | $393.84M | $475.20M | $295.28M |
Total Liabilities | $843.20M | $472.66M | $721.37M | $545.82M |
Cash & Equivalents | $74.88M | $46.34M | $238.48M | $69.77M |
Free Cash Flow OCF − CapEx | $13.69M | $32.82M | $-8.35M | $-88.27M |
Shares Outstanding | 307.83M | 302.96M | 270.03M | 263.79M |